{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:09Z","timestamp":1783488309027,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11102-025-01607-z","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:14:14Z","timestamp":1762953254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)"],"prefix":"10.1007","volume":"28","author":[{"given":"Brigitte","family":"Delemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona M.","family":"Florea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Decoudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Boulagnon-Rombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Pellegata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"P\u00e9trossians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/SCIENCE.2006410","volume":"251","author":"EM Blackwood","year":"1991","unstructured":"Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211\u20131217. https:\/\/doi.org\/10.1126\/SCIENCE.2006410","journal-title":"Science"},{"key":"1607_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbagrm.2014.05.016","volume":"1849","author":"D Diolaiti","year":"2015","unstructured":"Diolaiti D, McFerrin L, Carroll PA, Eisenman RN (2015) Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochim Biophys Acta 1849:484\u2013500. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.05.016","journal-title":"Biochim Biophys Acta"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/J.CELS.2018.03.003","volume":"6","author":"FX Schaub","year":"2018","unstructured":"Schaub FX, Dhankani V, Berger AC et al (2018) Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas. Cell Syst 6:282-300e2. https:\/\/doi.org\/10.1016\/J.CELS.2018.03.003","journal-title":"Cell Syst"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ccell.2020.04.016","volume":"38","author":"A Augert","year":"2020","unstructured":"Augert A, Mathsyaraja H, Ibrahim AH et al (2020) MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer. Cancer Cell 38:97-114e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.016","journal-title":"Cancer Cell"},{"issue":"5","key":"1607_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1541-7786.MCR-16-0376","volume":"15","author":"MA Pantaleo","year":"2017","unstructured":"Pantaleo MA, Urbini M, Indio V et al (2017) Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in quadruple WT GIST. Mol Cancer Res 15(5):553\u2013562. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0376","journal-title":"Mol Cancer Res"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/J.1442-200X.1999.01140.X","volume":"41","author":"Y Yuza","year":"1999","unstructured":"Yuza Y, Kawakami M, Takagi K et al (1999) Max protein expression is associated with survival of children with lymphoblastic lymphoma. Pediatr Int 41:637\u2013640. https:\/\/doi.org\/10.1046\/J.1442-200X.1999.01140.X","journal-title":"Pediatr Int"},{"key":"1607_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.7.3470","volume":"15","author":"R Hopewell","year":"1995","unstructured":"Hopewell R, Ziff EB (1995) The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner max. Mol Cell Biol 15:3470. https:\/\/doi.org\/10.1128\/MCB.15.7.3470","journal-title":"Mol Cell Biol"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-M\u00e9ndez","year":"2011","unstructured":"Comino-M\u00e9ndez I, Gracia-Azn\u00e1rez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663\u2013667. https:\/\/doi.org\/10.1038\/ng.861","journal-title":"Nat Genet"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Cascon A, Schiavi F et al (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18:2828\u20132837. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/JAMAONCOL.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y et al (2017) Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol 3:1204\u20131212. https:\/\/doi.org\/10.1001\/JAMAONCOL.2017.0223","journal-title":"JAMA Oncol"},{"key":"1607_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2024.1442691","volume":"15","author":"B Lian","year":"2024","unstructured":"Lian B, Lu J, Fang X et al (2024) Genotype and clinical phenotype characteristics of MAX germline mutation\u2013associated pheochromocytoma\/paraganglioma syndrome. Front Endocrinol (Lausanne) 15:1442691. https:\/\/doi.org\/10.3389\/FENDO.2024.1442691","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"L37","DOI":"10.1530\/ERC-18-0065","volume":"25","author":"AF Daly","year":"2018","unstructured":"Daly AF, Castermans E, Oudijk L et al (2018) Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocr Relat Cancer 25:L37\u2013L42. https:\/\/doi.org\/10.1530\/ERC-18-0065","journal-title":"Endocr Relat Cancer"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1055\/a-1186-0790","volume":"52","author":"S Petignot","year":"2020","unstructured":"Petignot S, Daly AF, Castermans E et al (2020) Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Horm Metab Res 52:784\u2013787. https:\/\/doi.org\/10.1055\/a-1186-0790","journal-title":"Horm Metab Res"},{"key":"1607_CR14","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2018-0146","volume":"4","author":"AO Kobza","year":"2018","unstructured":"Kobza AO, Dizon S, Arnaout A (2018) Case report of bilateral pheochromocytomas due to a novel MAX mutation in a patient known to have a pituitary prolactinoma. AACE Clin Case Rep 4:e453\u2013e456. https:\/\/doi.org\/10.4158\/ACCR-2018-0146","journal-title":"AACE Clin Case Rep"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/CLINEM\/DGAA957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook AJ, Harris JE, Velosa SB et al (2021) Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J Clin Endocrinol Metab 106:1163\u20131182. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA957","journal-title":"J Clin Endocrinol Metab"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/JC.2015-2592","volume":"101","author":"E Korpershoek","year":"2016","unstructured":"Korpershoek E, Koffy D, Eussen BH et al (2016) Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis. J Clin Endocrinol Metab 101:453\u2013460. https:\/\/doi.org\/10.1210\/JC.2015-2592","journal-title":"J Clin Endocrinol Metab"},{"key":"1607_CR17","unstructured":"IARC (2025) Endocrine and neuroendocrine tumours, 5th ed., vol 10. International Agency for Research on Cancer"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/S12020-025-04186-Y","volume":"88","author":"A Haider","year":"2025","unstructured":"Haider A, Sundar J, Beckers A et al (2025) Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant. Endocrine 88:701\u2013705. https:\/\/doi.org\/10.1007\/S12020-025-04186-Y","journal-title":"Endocrine"},{"key":"1607_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ADT3177","author":"B Freie","year":"2025","unstructured":"Freie B, Ibrahim AH, Carroll PA et al (2025) MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues. Sci Adv. https:\/\/doi.org\/10.1126\/SCIADV.ADT3177","journal-title":"Sci Adv"},{"key":"1607_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PCBI.1004873","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC (2016) CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/JOURNAL.PCBI.1004873","journal-title":"PLoS Comput Biol"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1530\/EJE-20-0054","volume":"183","author":"G Mougel","year":"2020","unstructured":"Mougel G, Lagarde A, Albarel F et al (2020) Germinal defects of SDHx genes in patients with isolated pituitary adenoma. Eur J Endocrinol 183:369\u2013379. https:\/\/doi.org\/10.1530\/EJE-20-0054","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01607-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:47:02Z","timestamp":1765961222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01607-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01607-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7760856\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-7760856\/v1","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}